P A Fasching1, F Thiel2, K Nicolaisen-Murmann2, C Rauh2, J Engel2, M P Lux2, M W Beckmann2, M R Bani2. 1. Department of Gynecology and Obstetrics, University of Erlangen, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. peter.fasching@gyn.med.uni-erlangen.de. 2. Department of Gynecology and Obstetrics, University of Erlangen, Universitaetsstrasse 21-23, 91054, Erlangen, Germany.
Abstract
GOALS OF WORK: In gynecological oncology, there is growing interest in the use of complementary and alternative medicine (CAM) methods. The lack of data regarding side effects, the lack of any survival advantages, and the costs of these methods appear to have no influence on patients' decisions on whether to use CAM. Our interest was to evaluate the association between CAM use and the patients' quality of life/life satisfaction (QoL/LS). MATERIALS AND METHODS: One thousand thirty women with breast cancer of gynecologic malignancies were asked to participate in this study, which included a questionnaire and a personal interview on CAM. User status was compared with the patient's own description of her QoL/LS and with the cancer type. MAIN RESULTS: CAM was used by 48.7% of all women (n = 502). Breast cancer patients stated that they used CAM in 50.1% and women with gynecological cancer in 44.0%. The use of mistletoe was widespread (77.3%) and was more often seen in breast cancer patients than in gynecological cancer patients (74.4% vs 67.0%). CAM users less frequently stated an overall deterioration of their health status (35.1%) compared to nonusers (50.1%). CAM use resulted in a stated improvement in family conditions (6%) in comparison with the nonusers (2%). CONCLUSIONS: With regard to patients' perception of health status, CAM use is associated with a better coping with their disease. Most other categories of LS are not affected by CAM use. Patient-oriented information comparing standard therapies with CAM methods should be made widely available, and patients' expectations of CAM use should be discussed between the physician and the patient.
GOALS OF WORK: In gynecological oncology, there is growing interest in the use of complementary and alternative medicine (CAM) methods. The lack of data regarding side effects, the lack of any survival advantages, and the costs of these methods appear to have no influence on patients' decisions on whether to use CAM. Our interest was to evaluate the association between CAM use and the patients' quality of life/life satisfaction (QoL/LS). MATERIALS AND METHODS: One thousand thirty women with breast cancer of gynecologic malignancies were asked to participate in this study, which included a questionnaire and a personal interview on CAM. User status was compared with the patient's own description of her QoL/LS and with the cancer type. MAIN RESULTS: CAM was used by 48.7% of all women (n = 502). Breast cancerpatients stated that they used CAM in 50.1% and women with gynecological cancer in 44.0%. The use of mistletoe was widespread (77.3%) and was more often seen in breast cancerpatients than in gynecological cancerpatients (74.4% vs 67.0%). CAM users less frequently stated an overall deterioration of their health status (35.1%) compared to nonusers (50.1%). CAM use resulted in a stated improvement in family conditions (6%) in comparison with the nonusers (2%). CONCLUSIONS: With regard to patients' perception of health status, CAM use is associated with a better coping with their disease. Most other categories of LS are not affected by CAM use. Patient-oriented information comparing standard therapies with CAM methods should be made widely available, and patients' expectations of CAM use should be discussed between the physician and the patient.
Authors: Mirjam A G Sprangers; Carol M Moinpour; Timothy J Moynihan; Donald L Patrick; Dennis A Revicki Journal: Mayo Clin Proc Date: 2002-06 Impact factor: 7.616
Authors: H Kappauf; D Leykauf-Ammon; U Bruntsch; M Horneber; G Kaiser; G Büschel; W M Gallmeier Journal: Support Care Cancer Date: 2000-07 Impact factor: 3.603
Authors: Wendy A Weiger; Michael Smith; Heather Boon; Mary Ann Richardson; Ted J Kaptchuk; David M Eisenberg Journal: Ann Intern Med Date: 2002-12-03 Impact factor: 25.391
Authors: Patricia A Ganz; Lorna Kwan; Annette L Stanton; Janice L Krupnick; Julia H Rowland; Beth E Meyerowitz; Julienne E Bower; Thomas R Belin Journal: J Natl Cancer Inst Date: 2004-03-03 Impact factor: 13.506
Authors: Cara L McDermott; David K Blough; Catherine R Fedorenko; Neeraj K Arora; Steven B Zeliadt; Megan E Fairweather; Ingrid Oakley-Girvan; Stephen K Van Den Eeden; Scott D Ramsey Journal: Support Care Cancer Date: 2010-12-01 Impact factor: 3.603
Authors: Patricia L Judson; Elizabeth L Dickson; Peter A Argenta; Yin Xiong; Melissa A Geller; Linda F Carson; Rahel Ghebre; Amy L Jonson; Levi S Downs Journal: Gynecol Oncol Date: 2011-08-23 Impact factor: 5.482
Authors: Ketty Mobed; Raymond Liu; Susan Stewart; Margaret Wrensch; Lucie McCoy; Terri Rice; Michael Prados; Susan Chang Journal: J Support Oncol Date: 2009 Nov-Dec
Authors: F Siedentopf; I Utz-Billing; S Gairing; W Schoenegg; H Kentenich; I Kollak Journal: Geburtshilfe Frauenheilkd Date: 2013-04 Impact factor: 2.915
Authors: C C Hack; P Voiß; S Lange; A E Paul; S Conrad; G J Dobos; M W Beckmann; S Kümmel Journal: Geburtshilfe Frauenheilkd Date: 2015-07 Impact factor: 2.915